Interview by Nicola Miller RARE Revolution,
Featuring Dr Martin Turner, director of policy and external affairs, and Rosie Lindup, senior policy and public affairs manager,Bioindustry Association (BIA)

“There obviously has been some highly innovative rare diseases products that have managed to navigate the UK’s regulatory reimbursement processes. But there also are many that haven’t, and some of those have been made available in European countries. It’s not just in comparison to the US that we’re slightly behind.” Rosie

---